No Risk from Delayed Appendectomy - ABC News
Links shared publicly online about this topic.
- 845total visits
No Risk from Delayed Appendectomy - ABC News
View full resource at abcnews.go.com
Tags: Emergency, News, First Aid and Emergency, Medical
Most Recently Shared on September 26, 2010 at 12:55 pm By:
No Risk From Delayed Appendectomy: Putting off the procedure for 12 hours or more is OK, researchers say. ... http://bit.ly/a5WyHv
Also Shared By:
Empathetic Middle School Teachers Lower Teen Alcohol Risk | Psych Central News
psychcentral.com — “A new study suggests emotional support from middle school teachers may often delay alcohol and other illicit substance use by teens. Researchers determined” View full resource at psychcentral.com
Most Recently Shared on March 22, 2012 at 2:07 pm By:
Reclaiming Futures Health Organization
Emphathetic middle school teachers lower teen alcohol risk: http://t.co/XVR4FH9A
Empathetic Middle School Teachers Lower Teen Alcohol Risk | Psych Central News
psychcentral.com — “A new study suggests emotional support from middle school teachers may often delay alcohol and other illicit substance use by teens. Researchers determined” View full resource at psychcentral.com
Most Recently Shared on March 22, 2012 at 12:43 pm By:
News: Empathetic Middle School Teachers Lower Teen Alcohol Risk http://t.co/ZhSdGCEF
NRDC in the News 3/20: Fuel efficiency for gas price relief, Keystone XL economic risks, energy efficiency standards and more... | NRDC News's Blog | Switchboard, from NRDC
switchboard.nrdc.org — “Thom Cmar criticized the Coast Guard for putting weak standards into their long-delayed national ballast water regulations, the source of many of the nation’s most vexing aquatic invasive species, in an Associated Press article… In the National Journal, Roland Hwang...” View full resource at switchboard.nrdc.org
Most Recently Shared on March 21, 2012 at 2:52 am By:
NRDC News 3/20: Fuel efficiency for gas price relief, Keystone XL economic risks, energy efficiency standards and more http://t.co/BS3hZJwC
Medical News: NIH Panel Backs Delayed Therapy for Prostate Cancer - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “Active surveillance is a viable option that should be offered to low-risk patients, according to a draft statement issued by the panel.” View full resource at medpagetoday.com
Most Recently Shared on December 8, 2011 at 5:32 am By:
Urology & Nephrology OW Health
NIH Panel Backs Delayed Therapy for Prostate Cancer: (MedPage Today) -- Active surveillance is a viable option t... http://t.co/MGJ9qRip
Medical News: Add a Mile to Walk Off Diabetes Risk - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Walking more not only wards off weight gain in middle age but also helps prevent or delay diabetes, a population-based study in Australia affirmed.” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 8:28 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: Add a Mile to Walk Off Diabetes Risk - http://t.co/dkSUMygu from @medpagetoday #health #medicine
Medical News: Estimated Autism Recurrence Rate Goes Up - in Pediatrics, Autism from MedPage Today
medpagetoday.com — “Among families who have a child with an autism spectrum disorder (ASD), the risk of a subsequent child developing an ASD may be higher than previously estimated, a multicenter study showed.” View full resource at medpagetoday.com
Most Recently Shared on August 15, 2011 at 5:06 am By:
Jay Gordon, MD, FAAP Doctor, Pediatrician, Health Communicator, and Physician
Some toxins could be environmental triggers to a genetic predisposition to autism http://t.co/U60tnKZ I include vaccines on my list
Closely Monitoring Low-Risk Prostate Cancer, with Biopsy, Does Not Raise Risk of Death and Discourages Overtreatment
newswise.com — “A Johns Hopkins study of 769 men from across the United States recently diagnosed with low-grade prostate cancer shows that forgoing immediate surgery to remove the tumor or radiation poses no added risk of death. Delaying treatment is fine, the results show, so long as the cancer--™s progression and tumor growth are closely monitored through --active surveillance-- and there is no dramatic worsening of the disease over time.” View full resource at newswise.com
Most Recently Shared on April 12, 2011 at 5:02 pm By:
#health news: Closely Monitoring Low-Risk Prostate Cancer, with Biopsy, Does Not Raise Risk of Death and Discour... http://bit.ly/gAIj4o
Medical News: Add a Mile to Walk Off Diabetes Risk - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Walking more not only wards off weight gain in middle age but also helps prevent or delay diabetes, a population-based study in Australia affirmed.” View full resource at medpagetoday.com
Most Recently Shared on January 13, 2011 at 11:41 pm By:
Add a Mile to Walk Off Diabetes Risk (CME/CE) http://bit.ly/hExVre
Timely Surgery Appears to Cut Infection Risk, Costs - Drugs.com MedNews
drugs.com — “Delaying elective surgery after a patient is admitted to the hospital increases the risk of complications from infections and results in higher hospital costs,” View full resource at drugs.com
Most Recently Shared on December 22, 2010 at 10:16 pm By:
Drugs and Devices OW OW Health
Timely Surgery Appears to Cut Infection Risk, Costs: WEDNESDAY, Dec. 22 -- Delaying elective surgery after... http://bit.ly/fG68JX #drug
Medical News: SABCS: Newer Drug Prevents CA Bone Met Risks Longer - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- The injectable anti-bone metastasis drug denosumab (Xgeva) delays skeletal complications of breast cancer five months longer than zoledronic acid (Zometa), an intravenous bisphosphonate” View full resource at medpagetoday.com
Most Recently Shared on December 12, 2010 at 7:12 pm By:
SABCS: Newer Drug Prevents CA Bone Met Risks Longer (CME/CE) http://bit.ly/h6fFah
Bevacizumab Delays Disease Progression in Ovarian Cancer - QualityPoint Technologies
qualitypointtech.net — “Early results from a phase 3 trial add evidence that bevacizumab plus standard therapy reduces the risk for disease progression. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 18, 2010 at 3:17 pm By:
Bevacizumab Delays Disease Progression in Ovarian Cancer: Early results from a phase 3 trial add evidence that bev... http://bit.ly/cxV7tR
Cancer-Fighting Bone Drugs Might Raise Stroke Risk - Drugs.com MedNews
drugs.com — “A new study finds that cancer patients treated with bisphosphonate drugs such as Aredia or Zometa to reduce or delay bone complications from cancer may be at hi” View full resource at drugs.com
Most Recently Shared on October 13, 2010 at 12:15 am By:
Cancer-Fighting Bone Drugs Might Raise Stroke Risk - http://bit.ly/arADae
Promising Early Results Suggest Bevacizumab Delays Progression In Newly Diagnosed Ovarian Cancer - Drugs.com MedNews
drugs.com — “Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of” View full resource at drugs.com
Most Recently Shared on October 12, 2010 at 10:12 pm By:
Drugs and Devices OW OW Health
Promising Early Results Suggest Bevacizumab Delays Progression In Newly Diagnosed Ovarian Cancer: Early resul... http://bit.ly/9HMpQX #drug
Cancer-Fighting Bone Drugs Might Raise Stroke Risk - Drugs.com MedNews
drugs.com — “A new study finds that cancer patients treated with bisphosphonate drugs such as Aredia or Zometa to reduce or delay bone complications from cancer may be at hi” View full resource at drugs.com
Most Recently Shared on October 12, 2010 at 9:05 pm By:
Drugs and Devices OW OW Health
Cancer-Fighting Bone Drugs Might Raise Stroke Risk: TUESDAY, Oct. 12 -- A new study finds that cancer patient... http://bit.ly/dhzEC4 #drug
Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer
news-medical.net — “Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment. At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, Dr Tim Perren from Leeds Teaching Hospitals NHS Trust, UK, reported findings from the international ICON7 trial, which included 1528 women with high-risk early or advanced stage epithelial ovar” View full resource at news-medical.net
Most Recently Shared on October 12, 2010 at 3:08 am By:
Ovarian Cancer News: Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer: Early ... http://buzzup.com/1ceso
Advertisement
HealthIT Policy
@HITpol
No Risk From Delayed Appendectomy: Putting off the procedure for 12 hours or more is OK, researchers say. ... http://bit.ly/a5WyHv
1 year ago...